OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“Spice”-related deaths in and around Munich, Germany: A retrospective look at the role of synthetic cannabinoid receptor agonists in our post-mortem cases over a seven-year period (2014–2020)
Olwen Groth, Gabriele Roider, Verena Angerer, et al.
International Journal of Legal Medicine (2023) Vol. 137, Iss. 4, pp. 1059-1069
Open Access | Times Cited: 13

Showing 13 citing articles:

ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market
Arianna Giorgetti, Annette Zschiesche, Olwen Groth, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 11, pp. 1350-1365
Open Access | Times Cited: 5

NMR Spectroscopic Reference Data of Synthetic Cannabinoids Sold on the Internet
Eva‐Maria Hubner, Martin G. Schmid, Verina Manojlović, et al.
Magnetic Resonance in Chemistry (2025) Vol. 63, Iss. 3, pp. 241-255
Open Access

Analysis of NPS in post-mortem samples in forensic toxicology
José Manuel Matey, Luis Manuel Menéndez-Quintanal, Begoña Bravo Serrano, et al.
Comprehensive analytical chemistry (2025)
Closed Access

The State of the Art in Post-Mortem Redistribution and Stability of New Psychoactive Substances in Fatal Cases: A Review of the Literature
Luis Manuel Menéndez-Quintanal, José Manuel Matey, Virginia Gallo González, et al.
Psychoactives (2024) Vol. 3, Iss. 4, pp. 525-610
Open Access | Times Cited: 3

Detecting novel psychoactive substances around the world
Alberto Salomone, Marco Vincenti
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 258-263
Closed Access | Times Cited: 2

Potential Implications of Multi-Drug Exposure with Synthetic Cannabinoids: A Scoping Review of Human Case Studies
Lucy R. Thomsen, Rhonda J. Rosengren, Michelle Glass
Psychoactives (2024) Vol. 3, Iss. 3, pp. 365-383
Open Access | Times Cited: 2

Toxicokinetic modelling of the synthetic cannabinoid 5F‐MDMB‐P7AICA and its main metabolite in pigs following pulmonary administration
Adrian A. Doerr, Christiane Dings, Omar Zaher, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 2

Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor
Hideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 21, pp. 3928-3940
Open Access | Times Cited: 5

Turning down the spice: tackling the problems of synthetic cannabinoids
Martine Skumlien, Sam Craft, Jenny Scott, et al.
BMJ (2023), pp. e076611-e076611
Closed Access | Times Cited: 2

Cardiac effects of 5F-Cumyl-PEGACLONE
Nicole Esdar, Evelyn Pawlik, Simon B. Eickhoff, et al.
International Journal of Legal Medicine (2024) Vol. 138, Iss. 3, pp. 823-831
Open Access

Substance Misuse: Substance Abuse—Patterns and Statistics
Christopher M. Milroy
Elsevier eBooks (2024), pp. 439-444
Closed Access

A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor
Hideaki Yano, Rezvan Chitsazi, Christopher Lucaj, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Page 1

Scroll to top